2007
DOI: 10.1186/cc5872
|View full text |Cite
|
Sign up to set email alerts
|

Reliability of arterial, capillary and venous point-of-care glucose measurements in the intensive care unit setting: evaluation of two glucometers

Abstract: Sepsis, the body's response to infection, is associated with extremely high mortality rates. Why a protective mechanism turns into a deadly clinical picture is a matter of debate, and goes largely unexplained. In previous work we demonstrated that platelet-derived microparticles (MP) can induce endothelial and vascular smooth muscle cell apoptosis in septic patients through NADPH oxidasedependent superoxide release [1]. In this work we sought to create a model for ex vivo generation of septic-like MP and to id… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2009
2009
2020
2020

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
1
0
1
Order By: Relevance
“…About 10% of our ICU patients are receiving an insulin infusion at any given time, and local policy mandates second-hourly ABG tests for these patients owing to concerns regarding the reliability of bedside glucometers in critically ill patients. 29 This alone would account for 15 000-20 000 samples annually, or about 40% of our ABG tests in the period after the intervention. When combined with other protocol-mandated ABG tests, such as for patients on continuous renal replacement therapy and those with diabetic ketoacidosis, the potential for further reductions in the number of tests at our institution is limited.…”
Section: Local Implicationsmentioning
confidence: 99%
“…About 10% of our ICU patients are receiving an insulin infusion at any given time, and local policy mandates second-hourly ABG tests for these patients owing to concerns regarding the reliability of bedside glucometers in critically ill patients. 29 This alone would account for 15 000-20 000 samples annually, or about 40% of our ABG tests in the period after the intervention. When combined with other protocol-mandated ABG tests, such as for patients on continuous renal replacement therapy and those with diabetic ketoacidosis, the potential for further reductions in the number of tests at our institution is limited.…”
Section: Local Implicationsmentioning
confidence: 99%
“…Mais recentemente têm se demonstrado que os glicosímetros para uso à beira-leito apresentam baixa precisão (111)(112)(113).…”
Section: Evidências Clínicasunclassified